Get the content you want anytime you want.
REGISTER NOW | SIGN IN
The Best Infectious Disease News Delivered Weekly

The Contagion® Influenza specialty page provides influenza-specific clinical news and articles, coverage from conferences and meetings, links to condition-specific resources, and videos and other content.

INFLUENZA NEWS - Page 1

More Flu Deaths Reported in US Cities with Pro Sports Teams
With the current COVID-19 outbreak, new data about Influenza mortality related to spectator sports should make the professional leagues and fans pause about attending games.
Phase 3 Study for Baloxavir Shows Efficacy in High-Risk Influenza Patients
Baloxavir marboxil showed superiority over placebo and similar efficacy to oseltamir in reducing influenza symptoms. 
 
How Deadly Was the 2019-2020 Flu Season?
While COVID-19 may have impacted flu-like illness reporting, the CDC estimates there were between 24,000-62,000 related deaths this year.
Why Comparing Flu and COVID-19 Severity Is Not Equivalent
Experts argue that though public officials may liken coronavirus to "just another flu," the true numbers show a stark difference.
 
Comparing Sensitivities: RT-PCR Versus Rapid Influenza Diagnostic Test
It is known that the type of respiratory specimen, sampling environmental factors, and time from symptom onset impact the sensitivity of rapid influenza diagnostic tests.
Getting Full Series of Flu Vaccine Doses Increases Effectiveness
Flu burden for children can be reduced by improving adherence to a 2-dose series of flu vaccinations. 
How COVID-19 Might Spread Through 2021
A team of investigators lay out 3 scenarios for the global pandemic duration—based on previous pandemic learning and public health adherence.
The Latest on Baloxavir, Concurrent Diagnoses for Adults with the Influenza, and Other Flu News
As the influenza season for 2019-20 comes to a close, Contagion® has the latest on baloxavir and what other infections adults with the flu may have.
FEATURED
Is there a cure? How long until we find it? And will it work for the majority of people living with HIV?